Walela

Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have dual agonistic capabilities and are engineered for increased avidity. These antibodies are designed to effectively and safely deliver potent monotherapy for cancer treatment, with a wide range of potential uses in the field of oncology.

Orange Grove Bio (OGB) is a platform that specializes in investing and developing preclinical drugs, with the aim of decreasing the expenses associated with discovering medications and expediting their progression into clinical trials.

The Verschuren Centre assists in the advancement of sustainable technologies for cleantech companies and supports their efforts to enter the market.

FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive approach to treat chronic diseases using fibroblast cells. Their innovative research spans across several clinical pathways such as Disc Degeneration, Orthopedics, Multiple Sclerosis, and Cancer, and is supported by over 150 U.S. and International patents that have either been issued or are still pending. FibroBiologics' work stands as a testament to the development of cell therapy and represents the future of medical advancement.

A new class of programmable polymer nanoparticles is being developed by Nanite, a next-generation non-viral gene delivery business, for a variety of applications and indications. The business' AI-driven SAYER platform combines state-of-the-art, high-throughput experimental and computational methodologies to create delivery systems that are appropriate for their intended use and transport a variety of genetic cargoes with tissue selectivity.

a nonprofit organisation dedicated to reducing greenhouse gas emissions by genetically increasing CO2 collection and storage in trees

Love Lifesciences is creating a line of injection safety tools that will enhance patient comfort when administering injection drugs. The injection procedure is time-consuming, risky for unneeded pain, and typically causes worry and panic. The current injection approach also leaves a lot of possibility for error in terms of dosage and needle stick injuries. Since the procedure can be so unpleasant, people frequently refuse or stop using these injectable therapy choices. When these issues are present together, patients experience worse health outcomes. Our revised injection process gives patients full injection control while reducing the chance of error. Unnecessary fear, worry, and discomfort shouldn't interfere with patient treatment in any way.

Empatica is a startup that specializes in emotional computing and human data analytics. We create ground-breaking wearable technology with superior medical sensing. Our system consists of a pair of wristbands, software for desktop and smartphone computers, and real-time syncing with a cloud computing service.

Cybele utilizes unique technology to deliver high-effective solutions for human health.

Our goal is to build STEM pipelines for underserved and diverse communities via transformative hands-on experiences. Inquisitive minds and scientific enthusiasts can explore the biological sciences in the Citizen Science Lab, which is a hands-on laboratory. Through inquiry-based instruction and STEM enrichment, we welcome everyone to look around and do analyses. #TheCitizenScienceLab #STEMpire

The biotechnology company Sensorium Therapeutics was founded by eminent scientists, doctors, and thought leaders from Massachusetts General Hospital and Harvard University. It uses cutting-edge chemistry, neuroscience, and machine learning to create naturally derived psychoactive medicines for mental health. Sensorium's revolutionary Biodynamic Discovery Platform uses cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can provide transformative benefits to patients all over the world. This platform was inspired by the real-world human benefits of plants and fungi. To find out more, go to sensoriumbio.

Our mission at Rebus Biosystems is spatial omics without compromise. Get direct access to biological molecular resolution at the subcellular level in and across large tissue sections. You can concentrate on the targets that are most important to your research thanks to customizable assays. Early 2021 will see the release of a fully automated, integrated instrument for your lab. Access is now offered as part of our Spatial Omics as a Service offering.